Expression Levels of Tetraspanin KAI1/CD82 in Breast Cancers in North Indian Females

Singh, Richa; Bhatt, Madan Lal Brahma; Singh, Saurabh Pratap; Kumar, Vijay; Goel, Madhu Mati; Mishra, Durga Prasad; Srivastava, Kirti; Kumar, Rajendra

추천

검색

자료유형: 학술저널

저자정보: Singh, Richa (Department of Radiotherapy, King George's Medical University) Bhatt, Madan Lal Brahma (Department of Radiotherapy, King George's Medical University) Singh, Saurabh Pratap (Department of Hematology, Sanjay Gandhi Post Graduate Institute of Medical Sciences) Kumar, Vijay (Department of Surgical Oncology, King George's Medical University) Goel, Madhu Mati (Department of Pathology, King George's Medical University) Mishra, Durga Prasad (Endocrinology Division, Central Drug Research Institute [CSIR]) Srivastava, Kirti (Department of Radiotherapy, King George's Medical University) Kumar, Rajendra (Department of Radiotherapy, King George's Medical University)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제17권 제7호

발행연도: 2016.1

수록면: 3,431 - 3,436 (6page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Carcinogenesis is a multifaceted intricate cellular mechanism of transformation of the normal functions of a cell into neoplastic alterations. Metastasis may result in failure of conventional treatment and death Hence, research on metastatic suppressors in cancer is a high priority. The metastatic suppressor gene CD82, also known as KAI1, is a member of the transmembrane 4 superfamily which was first identified in carcinoma of prostate. Little work has been done on this gene in breast cancer. Herein, we aimed to determine the gene and protein level expression of CD82/KAI1 in breast cancer and its role as a prognosticator. Materials and Methods: In this study, 83 histologically proven cases of breast cancer and a similar number of controls were included. Patient age ranged from 18-70 years. Quantitative Real Time Polymerase Chain Reaction (q-RT PCR) and immunohistochemistry (IHC) were used to investigate KAI1 expression at gene and protein levels, respectively. Statistical analysis was done to correlate expression of KAI1 and clinicopathological parameters. Results: It was revealed that: (i) KAI1 was remarkably diminished in metastatic vs non metastatic breast cancer both at the gene and the protein levels (P < .05); (ii) KAI1 expression levels were strongly correlated with TNM staging, histological grade and advanced stage (p<0.001) and no association was found with any other studied parameter; (iii) Lastly, a significant correlation was observed between expression of KAI1 and overall median survival of BC patients (P = 0.04). Conclusions: Our results suggest that lack of expression of the KAI1 might indicate a more aggressive form of breast cancer. Loss of KAI1 may be considered a significant prognostic marker in predicting metastatic manifestation. When evaluated along with the clinical and pathological factors, KAI1 expression may be beneficial to tailor aggressive therapeutic strategies for such patients.

#Breast cancer #prognosis #metastasis #KAI1 #North India

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!